Related references
Note: Only part of the references are listed.Amyloid fibril protein nomenclature: 2012 recommendations from the Nomenclature Committee of the International Society of Amyloidosis
Jean D. Sipe et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2012)
Crystal structure of a conformation-dependent rabbit IgG Fab specific for amyloid prefibrillar oligomers
Hiromi Arai et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2012)
Novel One-step Immunoassays to Quantify α-Synuclein APPLICATIONS FOR BIOMARKER DEVELOPMENT AND HIGH-THROUGHPUT SCREENING
Michael Bidinosti et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Clinical trials in Alzheimer's disease': immunotherapy approaches
Julien Delrieu et al.
JOURNAL OF NEUROCHEMISTRY (2012)
Soluble A ss oligomer production and toxicity
Megan E. Larson et al.
JOURNAL OF NEUROCHEMISTRY (2012)
Antibody-Aided Clearance of Extracellular α-Synuclein Prevents Cell-to-Cell Aggregate Transmission
Eun-Jin Bae et al.
JOURNAL OF NEUROSCIENCE (2012)
An Effector-Reduced Anti-β-Amyloid (Aβ) Antibody with Unique Aβ Binding Properties Promotes Neuroprotection and Glial Engulfment of Aβ
Oskar Adolfsson et al.
JOURNAL OF NEUROSCIENCE (2012)
The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes
Iryna Benilova et al.
NATURE NEUROSCIENCE (2012)
Passive Immunization against Pyroglutamate-3 Amyloid-β Reduces Plaque Burden in Alzheimer-Like Transgenic Mice: A Pilot Study
Jeffrey L. Frost et al.
NEURODEGENERATIVE DISEASES (2012)
Large Aggregates Are the Major Soluble Ab Species in AD Brain Fractionated with Density Gradient Ultracentrifugation
Dag Sehlin et al.
PLOS ONE (2012)
Structure-based design of conformation- and sequence-specific antibodies against amyloid β
Joseph M. Perchiacca et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Molecular basis of β-amyloid oligomer recognition with a conformational antibody fragment
Isabel Morgado et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Tau Oligomers as Potential Targets for Immunotherapy for Alzheimers Disease and Tauopathies
C. A. Lasagna-Reeves et al.
Current Alzheimer Research (2011)
Finding a better path to drug selectivity
Yuko Kawasaki et al.
DRUG DISCOVERY TODAY (2011)
Elevated Levels of α-Synuclein Oligomer in the Cerebrospinal Fluid of Drug-Naive Patients with Parkinson's Disease
Min Jeong Park et al.
JOURNAL OF CLINICAL NEUROLOGY (2011)
Amyloid Fibril Recognition with the Conformational B10 Antibody Fragment Depends on Electrostatic Interactions
Christian Haupt et al.
JOURNAL OF MOLECULAR BIOLOGY (2011)
Passive immunization targeting pathological phospho-tau protein in a mouse model reduces functional decline and clears tau aggregates from the brain
Allal Boutajangout et al.
JOURNAL OF NEUROCHEMISTRY (2011)
Atomic-resolution dynamics on the surface of amyloid-β protofibrils probed by solution NMR
Nicolas L. Fawzi et al.
NATURE (2011)
PrPSc-Specific Antibodies with the Ability to Immunodetect Prion Oligomers
Mourad Tayebi et al.
PLOS ONE (2011)
Passive Immunization Reduces Behavioral and Neuropathological Deficits in an Alpha-Synuclein Transgenic Model of Lewy Body Disease
Eliezer Masliah et al.
PLOS ONE (2011)
Functional Links Between Aβ Toxicity, Endocytic Trafficking, and Alzheimer's Disease Risk Factors in Yeast
Sebastian Treusch et al.
SCIENCE (2011)
Preparation and Characterization of Neurotoxic Tau Oligomers
Cristian A. Lasagna-Reeves et al.
BIOCHEMISTRY (2010)
Restricted V gene usage and VH/VL pairing of mouse humoral response against the N terminal immunodominant epitope of the amyloid β peptide
Remy Robert et al.
MOLECULAR IMMUNOLOGY (2010)
Conformation dependent monoclonal antibodies distinguish different replicating strains or conformers of prefibrillar Aβ oligomers
Rakez Kayed et al.
MOLECULAR NEURODEGENERATION (2010)
Anti-ADDL antibodies differentially block oligomer binding to hippocampal neurons
P. J. Shughrue et al.
NEUROBIOLOGY OF AGING (2010)
Amyloid-β Oligomer Specificity Mediated by the IgM Isotype - Implications for a Specific Protective Mechanism Exerted by Endogenous Auto-Antibodies
Malin Lindhagen-Persson et al.
PLOS ONE (2010)
Targeting Generation of Antibodies Specific to Conformational Epitopes of Amyloid beta-Derived Neurotoxins
Mary P. Lambert et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2009)
Seeding induced by α-synuclein oligomers provides evidence for spreading of α-synuclein pathology
Karin M. Danzer et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Alzheimer's disease: synaptic dysfunction and Aβ
Ganesh M. Shankar et al.
MOLECULAR NEURODEGENERATION (2009)
Soluble fibrillar oligomer levels are elevated in Alzheimer's disease brain and correlate with cognitive dysfunction
Jennifer L. Tomic et al.
NEUROBIOLOGY OF DISEASE (2009)
A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease
S. Salloway et al.
NEUROLOGY (2009)
Formation of cytotoxic transthyretin is not dependent on inter-molecular disulphide bridges commonly found within the amyloid form
M. Lindhagen-Persson et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2008)
The use of conformation-specific ligands and assays to dissect the molecular mechanisms of neurodegenerative diseases
S. Rutger Leliveld et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2007)
Monoclonal antibodies that target pathological assemblies of A beta
Mary P. Lambert et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Intraneuronal A beta immunoreactivity is not a predictor of brain amyloidosis-beta or neurofibrillary degeneration
Jerzy Wegiel et al.
ACTA NEUROPATHOLOGICA (2007)
Targeting amyloid-β peptide (Aβ) oligomers by passive immunization with a conformation-selective monoclonal antibody improves learning and memory in Aβ precursor protein (APP) transgenic mice
EB Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Antibodies against β-amyloid reduce Aβ oligomers, glycogen synthase kinase-3β activation and τ phosphorylation in vivo and in vitro
QL Ma et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2006)
The solvent protection of Alzheimer amyloid-β-(1-42) fibrils as determined by solution NMR spectroscopy
A Olofsson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Common structure and toxic function of amyloid oligomers implies a common mechanism of pathogenesis
CG Glabe et al.
NEUROLOGY (2006)
The role of cell-derived oligomers of Aβ in Alzheimer's disease and avenues for therapeutic intervention
DM Walsh et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2005)
Comparison of rabbit monoclonal and mouse monoclonal antibodies in immunohistochemistry in canine tissues
JG Vilches-Moure et al.
JOURNAL OF VETERINARY DIAGNOSTIC INVESTIGATION (2005)
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis
R Kayed et al.
SCIENCE (2003)
Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo
DM Walsh et al.
NATURE (2002)
Conformational Abs recognizing a generic amyloid fibril epitope
B O'Nuallain et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formation
C Nilsberth et al.
NATURE NEUROSCIENCE (2001)
Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease:: Implications for pathogenesis and therapy
KA Conway et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity
J O'Brien et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2000)
Share Paper
